International Biotechnology (LON:IBT) Share Price Passes Above Two Hundred Day Moving Average – Here’s What Happened

International Biotechnology (LON:IBTGet Free Report) passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 683.02 ($8.40) and traded as high as GBX 699.84 ($8.61). International Biotechnology shares last traded at GBX 692 ($8.51), with a volume of 53,428 shares traded.

International Biotechnology Stock Down 0.9 %

The firm’s 50-day moving average price is GBX 695.12 and its 200 day moving average price is GBX 683.15. The company has a current ratio of 0.46, a quick ratio of 0.32 and a debt-to-equity ratio of 9.66. The company has a market capitalization of £255.76 million, a price-to-earnings ratio of 1,441.67 and a beta of 0.21.

International Biotechnology Increases Dividend

The firm also recently declared a dividend, which will be paid on Friday, January 24th. Stockholders of record on Thursday, December 19th will be paid a GBX 15.56 ($0.19) dividend. This is a positive change from International Biotechnology’s previous dividend of $14.50. The ex-dividend date of this dividend is Thursday, December 19th. This represents a dividend yield of 2.21%. International Biotechnology’s dividend payout ratio (DPR) is presently 6,041.67%.

Insider Transactions at International Biotechnology

In other International Biotechnology news, insider Katherine Cornish-Bowden bought 1,500 shares of the stock in a transaction on Tuesday, December 17th. The stock was purchased at an average price of GBX 713 ($8.77) per share, with a total value of £10,695 ($13,159.84). 4.18% of the stock is owned by insiders.

About International Biotechnology

(Get Free Report)

International Biotechnology Trust plc specializes in investments in development stage and late stage companies. The majority of the fund's assets are generally invested in smaller and mid-capitalization quoted companies, with a minority in larger capitalization quoted companies. It makes long only investments.

Further Reading

Receive News & Ratings for International Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.